Article Versions Notes

Gravina GL, Colapietro A, Mancini A, Rossetti A, Martellucci S, Ventura L, Di Franco M, Marampon F, Mattei V, Biordi LA, et al. ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma. Cancers. 2022; 14(2):289. https://doi.org/10.3390/cancers14020289

Gravina, Giovanni Luca, Alessandro Colapietro, Andrea Mancini, Alessandra Rossetti, Stefano Martellucci, Luca Ventura, Martina Di Franco, Francesco Marampon, Vincenzo Mattei, Leda Assunta Biordi, and et al. 2022. "ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma" Cancers 14, no. 2: 289. https://doi.org/10.3390/cancers14020289

Gravina, G. L., Colapietro, A., Mancini, A., Rossetti, A., Martellucci, S., Ventura, L., Di Franco, M., Marampon, F., Mattei, V., Biordi, L. A., Otterlei, M., & Festuccia, C. (2022). ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma. Cancers, 14(2), 289. https://doi.org/10.3390/cancers14020289